<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37122709</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>02</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>02</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Mitochondria in innate immunity signaling and its therapeutic implications in autoimmune diseases.</ArticleTitle><Pagination><StartPage>1160035</StartPage><MedlinePgn>1160035</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1160035</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2023.1160035</ELocationID><Abstract><AbstractText>Autoimmune diseases are characterized by vast alterations in immune responses, but the pathogenesis remains sophisticated and yet to be fully elucidated. Multiple mechanisms regulating cell differentiation, maturation, and death are critical, among which mitochondria-related cellular organelle functions have recently gained accumulating attention. Mitochondria, as a highly preserved organelle in eukaryotes, have crucial roles in the cellular response to both exogenous and endogenous stress beyond their fundamental functions in chemical energy conversion. In this review, we aim to summarize recent findings on the function of mitochondria in the innate immune response and its aberrancy in autoimmune diseases such as rheumatoid arthritis, systemic lupus erythematosus, etc., mainly focusing on its direct impact on cellular metabolism and its machinery on regulating immune response signaling pathways. More importantly, we summarize the status quo of potential therapeutic targets found in the mitochondrial regulation in the setting of autoimmune diseases and wish to shed light on future studies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Jiao, Yan and Yang.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiao</LastName><ForeName>Yuhao</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yan</LastName><ForeName>Zhiyu</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>4+4 Medical Doctor Program, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Aiming</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Gastroenterology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001327" MajorTopicYN="Y">Autoimmune Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008928" MajorTopicYN="N">Mitochondria</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007113" MajorTopicYN="N">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="Y">Arthritis, Rheumatoid</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">autoimmune disease</Keyword><Keyword MajorTopicYN="N">immune metabolism</Keyword><Keyword MajorTopicYN="N">innate immunity</Keyword><Keyword MajorTopicYN="N">mitochondria</Keyword><Keyword MajorTopicYN="N">therapeutic targets</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>2</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>1</Day><Hour>3</Hour><Minute>21</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37122709</ArticleId><ArticleId IdType="pmc">PMC10130412</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2023.1160035</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Henze K, Martin W. Essence of mitochondria. Nature (2003) 426(6963):127&#x2013;8. doi: 10.1038/426127a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/426127a</ArticleId><ArticleId IdType="pubmed">14614484</ArticleId></ArticleIdList></Reference><Reference><Citation>Emelyanov VV. Mitochondrial connection to the origin of the eukaryotic cell. Eur J Biochem (2003) 270(8):1599&#x2013;618. doi: 10.1046/j.1432-1033.2003.03499.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1432-1033.2003.03499.x</ArticleId><ArticleId IdType="pubmed">12694174</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin W, Hoffmeister M, Rotte C, Henze K. An overview of endosymbiotic models for the origins of eukaryotes, their ATP-producing organelles (mitochondria and hydrogenosomes), and their heterotrophic lifestyle. Biol Chem (2001) 381(11):1521&#x2013;39. doi: 10.1515/BC.2001.187</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/BC.2001.187</ArticleId><ArticleId IdType="pubmed">11767942</ArticleId></ArticleIdList></Reference><Reference><Citation>West AP, Brodsky IE, Rahner C, Woo DK, Erdjument-Bromage H, Tempst P, et al. . TLR signalling augments macrophage bactericidal activity through mitochondrial ROS. Nature (2011) 472(7344):476&#x2013;80. doi: 10.1038/nature09973</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09973</ArticleId><ArticleId IdType="pmc">PMC3460538</ArticleId><ArticleId IdType="pubmed">21525932</ArticleId></ArticleIdList></Reference><Reference><Citation>Banjara S, Suraweera CD, Hinds MG, Kvansakul M. The bcl-2 family: ancient origins, conserved structures, and divergent mechanisms. Biomolecules (2020) 10(1):128. doi: 10.3390/biom10010128</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom10010128</ArticleId><ArticleId IdType="pmc">PMC7022251</ArticleId><ArticleId IdType="pubmed">31940915</ArticleId></ArticleIdList></Reference><Reference><Citation>Soubannier V, McBride HM. Positioning mitochondrial plasticity within cellular signaling cascades. Biochim Biophys Acta (BBA)-Molecular Cell Res (2009) 1793(1):154&#x2013;70. doi: 10.1016/j.bbamcr.2008.07.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamcr.2008.07.008</ArticleId><ArticleId IdType="pubmed">18694785</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamanaka RB, Chandel NS. Mitochondrial reactive oxygen species regulate cellular signaling and dictate biological outcomes. Trends Biochem Sci (2010) 35(9):505&#x2013;13. doi: 10.1016/j.tibs.2010.04.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2010.04.002</ArticleId><ArticleId IdType="pmc">PMC2933303</ArticleId><ArticleId IdType="pubmed">20430626</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell (2007) 130(1):25&#x2013;35. doi: 10.1016/j.cell.2007.06.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.06.033</ArticleId><ArticleId IdType="pubmed">17632054</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang KS, Burow A, Kurrer M, Lang PA, Recher M. The role of the innate immune response in autoimmune disease. J Autoimmunity (2007) 29(4):206&#x2013;12. doi: 10.1016/j.jaut.2007.07.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2007.07.018</ArticleId><ArticleId IdType="pubmed">17904335</ArticleId></ArticleIdList></Reference><Reference><Citation>Waldner H, Collins M, Kuchroo VK. Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J Clin Invest (2004) 113(7):990&#x2013;7. doi: 10.1172/JCI19388</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI19388</ArticleId><ArticleId IdType="pmc">PMC379316</ArticleId><ArticleId IdType="pubmed">15057305</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao Y, Wu L, Huntington ND, Zhang X. Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases. Front Immunol (2020) 11:282. doi: 10.3389/fimmu.2020.00282</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00282</ArticleId><ArticleId IdType="pmc">PMC7047319</ArticleId><ArticleId IdType="pubmed">32153586</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol (2010) 11(5):373&#x2013;84. doi: 10.1038/ni.1863</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1863</ArticleId><ArticleId IdType="pubmed">20404851</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi O, Akira S. Pattern recognition receptors and inflammation. Cell (2010) 140(6):805&#x2013;20. doi: 10.1016/j.cell.2010.01.022</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.022</ArticleId><ArticleId IdType="pubmed">20303872</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchi S, Guilbaud E, Tait SWG, Yamazaki T, Galluzzi L. Mitochondrial control of inflammation. Nat Rev Immunol (2022) 23(3):159&#x2013;73. doi:&#xa0;10.1038/s41577-022-00760-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00760-x</ArticleId><ArticleId IdType="pmc">PMC9310369</ArticleId><ArticleId IdType="pubmed">35879417</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills EL, Kelly B, O&#x2019;Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol (2017) 18(5):488&#x2013;98. doi: 10.1038/ni.3704</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3704</ArticleId><ArticleId IdType="pubmed">28418387</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreyev AY, Kushnareva YE, Murphy AN, Starkov AA. Mitochondrial ROS metabolism: 10 years later. Biochem (Mosc) (2015) 80(5):517&#x2013;31. doi: 10.1134/S0006297915050028</Citation><ArticleIdList><ArticleId IdType="doi">10.1134/S0006297915050028</ArticleId><ArticleId IdType="pmc">PMC4511471</ArticleId><ArticleId IdType="pubmed">26071769</ArticleId></ArticleIdList></Reference><Reference><Citation>Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell (2005) 120(4):483&#x2013;95. doi: 10.1016/j.cell.2005.02.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.02.001</ArticleId><ArticleId IdType="pubmed">15734681</ArticleId></ArticleIdList></Reference><Reference><Citation>Nauseef WM. Assembly of the phagocyte NADPH oxidase. Histochem Cell Biol (2004) 122:277&#x2013;91. doi: 10.1007/s00418-004-0679-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00418-004-0679-8</ArticleId><ArticleId IdType="pubmed">15293055</ArticleId></ArticleIdList></Reference><Reference><Citation>F&#xf6;rstermann U, Sessa WC. Nitric oxide synthases: regulation and function. Eur Heart J (2012) 33(7):829&#x2013;37. doi: 10.1093/eurheartj/ehr304</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehr304</ArticleId><ArticleId IdType="pmc">PMC3345541</ArticleId><ArticleId IdType="pubmed">21890489</ArticleId></ArticleIdList></Reference><Reference><Citation>Perl A. Oxidative stress in the pathology and treatment of systemic lupus erythematosus. Nat Rev Rheumatol (2013) 9(11):674&#x2013;86. doi: 10.1038/nrrheum.2013.147</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrrheum.2013.147</ArticleId><ArticleId IdType="pmc">PMC4046645</ArticleId><ArticleId IdType="pubmed">24100461</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaitanya NS, Tammineni P, Nagaraju GP, Reddy AB. Pleiotropic roles of evolutionarily conserved signaling intermediate in toll pathway (ECSIT) in pathophysiology. J Cell Physiol (2022) 237(9):3496&#x2013;504. doi: 10.1002/jcp.30832</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.30832</ArticleId><ArticleId IdType="pubmed">35853181</ArticleId></ArticleIdList></Reference><Reference><Citation>Banoth B, Cassel SL. Mitochondria in innate immune signaling. Trans Res (2018) 202:52&#x2013;68. doi: 10.1016/j.trsl.2018.07.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trsl.2018.07.014</ArticleId><ArticleId IdType="pmc">PMC6218307</ArticleId><ArticleId IdType="pubmed">30165038</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiku V, Tan M-W, Dikic I. Mitochondrial functions in infection and immunity. Trends Cell Biol (2020) 30(4):263&#x2013;75. doi: 10.1016/j.tcb.2020.01.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2020.01.006</ArticleId><ArticleId IdType="pmc">PMC7126537</ArticleId><ArticleId IdType="pubmed">32200805</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang N, Perl A. Metabolism as a target for modulation in autoimmune diseases. Trends Immunol (2018) 39(7):562&#x2013;76. doi: 10.1016/j.it.2018.04.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.it.2018.04.006</ArticleId><ArticleId IdType="pubmed">29739666</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho TT, Warr MR, Adelman ER, Lansinger OM, Flach J, Verovskaya EV, et al. . Autophagy maintains the metabolism and function of young and old stem cells. Nature (2017) 543(7644):205&#x2013;10. doi: 10.1038/nature21388</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21388</ArticleId><ArticleId IdType="pmc">PMC5344718</ArticleId><ArticleId IdType="pubmed">28241143</ArticleId></ArticleIdList></Reference><Reference><Citation>Ushio-Fukai M, Rehman J. Redox and metabolic regulation of stem/progenitor cells and their niche. Antioxidants Redox Signaling (2014) 21(11):1587&#x2013;90. doi: 10.1089/ars.2014.5931</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2014.5931</ArticleId><ArticleId IdType="pmc">PMC4175426</ArticleId><ArticleId IdType="pubmed">25133592</ArticleId></ArticleIdList></Reference><Reference><Citation>Nestorowa S, Hamey FK, Pijuan Sala B, Diamanti E, Shepherd M, Laurenti E, et al. . A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation. Blood J Am Soc Hematology. (2016) 128(8):e20&#x2013;31. doi: 10.1182/blood-2016-05-716480</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2016-05-716480</ArticleId><ArticleId IdType="pmc">PMC5305050</ArticleId><ArticleId IdType="pubmed">27365425</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Y, Chen Y, Peng T, Li L, Zhu W, Liu F, et al. . Mitochondrial ROS-induced lysosomal dysfunction impairs autophagic flux and contributes to M1 macrophage polarization in a diabetic condition. Clin Sci (2019) 133(15):1759&#x2013;77. doi: 10.1042/CS20190672</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20190672</ArticleId><ArticleId IdType="pubmed">31383716</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan H-Y, Wang N, Li S, Hong M, Wang X, Feng Y. The reactive oxygen species in macrophage polarization: reflecting its dual role in progression and treatment of human diseases. Oxid Med Cell Longevity (2016). doi: 10.1155/2016/2795090</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2795090</ArticleId><ArticleId IdType="pmc">PMC4837277</ArticleId><ArticleId IdType="pubmed">27143992</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu R, Li X, Ma H, Yang Q, Shang Q, Song L, et al. . Spermidine endows macrophages anti-inflammatory properties by inducing mitochondrial superoxide-dependent AMPK activation, hif-1&#x3b1; upregulation and autophagy. Free Radical Biol Med (2020) 161:339&#x2013;50. doi: 10.1016/j.freeradbiomed.2020.10.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2020.10.029</ArticleId><ArticleId IdType="pubmed">33122005</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunelle JK, Bell EL, Quesada NM, Vercauteren K, Tiranti V, Zeviani M, et al. . Oxygen sensing requires mitochondrial ROS but not oxidative phosphorylation. Cell Metab (2005) 1(6):409&#x2013;14. doi: 10.1016/j.cmet.2005.05.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2005.05.002</ArticleId><ArticleId IdType="pubmed">16054090</ArticleId></ArticleIdList></Reference><Reference><Citation>Chandel NS, Trzyna WC, McClintock DS, Schumacker PT. Role of oxidants in NF-&#x3ba;B activation and TNF-&#x3b1; gene transcription induced by hypoxia and endotoxin. J Immunol (2000) 165(2):1013&#x2013;21. doi: 10.4049/jimmunol.165.2.1013</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.165.2.1013</ArticleId><ArticleId IdType="pubmed">10878378</ArticleId></ArticleIdList></Reference><Reference><Citation>Suomalainen A, Battersby BJ. Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat Rev Mol Cell Biol (2018) 19(2):77&#x2013;92. doi: 10.1038/nrm.2017.66</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm.2017.66</ArticleId><ArticleId IdType="pubmed">28792006</ArticleId></ArticleIdList></Reference><Reference><Citation>Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, et al. . Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med (2016) 22(2):146&#x2013;53. doi: 10.1038/nm.4027</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4027</ArticleId><ArticleId IdType="pmc">PMC4742415</ArticleId><ArticleId IdType="pubmed">26779811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, et al. . Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA&#x2013;peptide complexes in systemic lupus erythematosus. Sci Trans Med (2011) 3(73):73ra19&#x2013;9. doi: 10.1126/scitranslmed.3001180</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3001180</ArticleId><ArticleId IdType="pmc">PMC3399524</ArticleId><ArticleId IdType="pubmed">21389263</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang H, Li T, Chen S, Gu Y, Ye S. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin. Arthritis Rheumatol (2015) 67(12):3190&#x2013;200. doi: 10.1002/art.39296</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39296</ArticleId><ArticleId IdType="pubmed">26245802</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao J, Ma J, Deng Y, Kelly JA, Kim K, Bang S-Y, et al. . A missense variant in NCF1 is associated with susceptibility to multiple autoimmune diseases. Nat Genet (2017) 49(3):433&#x2013;7. doi: 10.1038/ng.3782</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.3782</ArticleId><ArticleId IdType="pmc">PMC5400098</ArticleId><ArticleId IdType="pubmed">28135245</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacob CO, Eisenstein M, Dinauer MC, Ming W, Liu Q, John S, et al. . Lupus-associated causal mutation in neutrophil cytosolic factor 2 (NCF2) brings unique insights to the structure and function of NADPH oxidase. Proc Natl Acad Sci (2012) 109(2):E59&#x2013;67. doi: 10.1073/pnas.1113251108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1113251108</ArticleId><ArticleId IdType="pmc">PMC3258621</ArticleId><ArticleId IdType="pubmed">22203994</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson LM, Johansson &#xc5;C, Gullstrand B, J&#xf6;nsen A, Saevarsdottir S, R&#xf6;nnblom L, et al. . A single nucleotide polymorphism in the NCF1 gene leading to reduced oxidative burst is associated with systemic lupus erythematosus. Ann rheumatic diseases. (2017) 76(9):1607&#x2013;13. doi: 10.1136/annrheumdis-2017-211287</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2017-211287</ArticleId><ArticleId IdType="pubmed">28606963</ArticleId></ArticleIdList></Reference><Reference><Citation>Oaks Z, Winans T, Caza T, Fernandez D, Liu Y, Landas SK, et al. . Mitochondrial dysfunction in the liver and antiphospholipid antibody production precede disease onset and respond to rapamycin in lupus-prone mice. Arthritis Rheumatol (2016) 68(11):2728&#x2013;39. doi: 10.1002/art.39791</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39791</ArticleId><ArticleId IdType="pmc">PMC5083168</ArticleId><ArticleId IdType="pubmed">27332042</ArticleId></ArticleIdList></Reference><Reference><Citation>Caza TN, Fernandez DR, Talaber G, Oaks Z, Haas M, Madaio MP, et al. . HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. Ann Rheum Dis (2014) 73(10):1888&#x2013;97. doi: 10.1136/annrheumdis-2013-203794</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2013-203794</ArticleId><ArticleId IdType="pmc">PMC4047212</ArticleId><ArticleId IdType="pubmed">23897774</ArticleId></ArticleIdList></Reference><Reference><Citation>Buskiewicz IA, Montgomery T, Yasewicz EC, Huber SA, Murphy MP, Hartley RC, et al. . Reactive oxygen species induce virus-independent MAVS oligomerization in systemic lupus erythematosus. Sci Signaling (2016) 9(456):ra115&#x2013;ra. doi: 10.1126/scisignal.aaf1933</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aaf1933</ArticleId><ArticleId IdType="pmc">PMC5321043</ArticleId><ArticleId IdType="pubmed">27899525</ArticleId></ArticleIdList></Reference><Reference><Citation>Fortner KA, Blanco LP, Buskiewicz I, Huang N, Gibson PC, Cook DL, et al. . Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice. Lupus Sci Med (2020) 7(1):e000387. doi: 10.1136/lupus-2020-000387</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2020-000387</ArticleId><ArticleId IdType="pmc">PMC7199895</ArticleId><ArticleId IdType="pubmed">32343673</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao P, He Y, Yang F, Luo G, Zhuang J, Zhai Z, et al. . Polydatin effectively attenuates disease activity in lupus-prone mouse models by blocking ROS-mediated NET formation. Arthritis Res Ther (2018) 20(1):1&#x2013;11. doi: 10.1186/s13075-018-1749-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-018-1749-y</ArticleId><ArticleId IdType="pmc">PMC6235205</ArticleId><ArticleId IdType="pubmed">30419963</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang G, Chang C-C, Yang Y, Yuan L, Xu L, Ho C-T, et al. . Resveratrol alleviates rheumatoid arthritis via reducing ROS and inflammation, inhibiting MAPK signaling pathways, and suppressing angiogenesis. J Agric Food Chem (2018) 66(49):12953&#x2013;60. doi: 10.1021/acs.jafc.8b05047</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.8b05047</ArticleId><ArticleId IdType="pubmed">30511573</ArticleId></ArticleIdList></Reference><Reference><Citation>Jing M, Yang J, Zhang L, Liu J, Xu S, Wang M, et al. . Celastrol inhibits rheumatoid arthritis through the ROS-NF-&#x3ba;B-NLRP3 inflammasome axis. Int Immunopharmacol (2021) 98:107879. doi: 10.1016/j.intimp.2021.107879</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2021.107879</ArticleId><ArticleId IdType="pubmed">34147915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SR, Han J. Mitochondrial mutations in cardiac disorders. In: Santulli G, editor. Mitochondrial dynamics in cardiovascular medicine. Cham: Springer International Publishing; (2017). p. 81&#x2013;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">28551783</ArticleId></ArticleIdList></Reference><Reference><Citation>De Gaetano A, Solodka K, Zanini G, Selleri V, Mattioli AV, Nasi M, et al. . Molecular mechanisms of mtDNA-mediated inflammation. Cells (2021) 10(11):2898. doi: 10.3390/cells10112898</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10112898</ArticleId><ArticleId IdType="pmc">PMC8616383</ArticleId><ArticleId IdType="pubmed">34831121</ArticleId></ArticleIdList></Reference><Reference><Citation>Mechta M, Ingerslev LR, Fabre O, Picard M, Barr&#xe8;s R. Evidence suggesting absence of mitochondrial DNA methylation. Front Genet (2017) 8:166. doi: 10.3389/fgene.2017.00166</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2017.00166</ArticleId><ArticleId IdType="pmc">PMC5671948</ArticleId><ArticleId IdType="pubmed">29163634</ArticleId></ArticleIdList></Reference><Reference><Citation>Nass MM. Differential methylation of mitochondrial and nuclear DNA in cultured mouse, hamster and virus-transformed hamster cells in vivo and in vitro methylation. J Mol Biol (1973) 80(1):155&#x2013;75. doi: 10.1016/0022-2836(73)90239-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-2836(73)90239-8</ArticleId><ArticleId IdType="pubmed">4361747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hajizadeh S, DeGroot J, TeKoppele JM, Tarkowski A, Collins LV. Extracellular mitochondrial DNA and oxidatively damaged DNA in synovial fluid of patients with rheumatoid arthritis. Arthritis Res Ther (2003) 5:1&#x2013;7. doi: 10.1186/ar787</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar787</ArticleId><ArticleId IdType="pmc">PMC193725</ArticleId><ArticleId IdType="pubmed">12932286</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, et al. . Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Trans Med (2011) 3(73):73ra20&#x2013;0. doi: 10.1126/scitranslmed.3001201</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3001201</ArticleId><ArticleId IdType="pmc">PMC3143837</ArticleId><ArticleId IdType="pubmed">21389264</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyapati RK, Tamborska A, Dorward DA, Ho G-T. Advances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases. F1000Research (2017) 6:169. doi: 10.12688/f1000research.10397.1</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.10397.1</ArticleId><ArticleId IdType="pmc">PMC5321122</ArticleId><ArticleId IdType="pubmed">28299196</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins LV, Hajizadeh S, Holme E, Jonsson IM, Tarkowski A. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. J Leukocyte Biol (2004) 75(6):995&#x2013;1000. doi: 10.1189/jlb.0703328</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.0703328</ArticleId><ArticleId IdType="pubmed">14982943</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker Y, Marcoux G, Allaeys I, Julien A-S, Loignon R-C, Benk-Fortin H, et al. . Autoantibodies in systemic lupus erythematosus target mitochondrial RNA. Front Immunol (2019) 10:1026. doi: 10.3389/fimmu.2019.01026</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01026</ArticleId><ArticleId IdType="pmc">PMC6524553</ArticleId><ArticleId IdType="pubmed">31134086</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J, Wu B, Goodman SB, Berry GJ, Goronzy JJ, Weyand CM. Metabolic control of autoimmunity and tissue inflammation in rheumatoid arthritis. Front Immunol (2021) 12:652771. doi: 10.3389/fimmu.2021.652771</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.652771</ArticleId><ArticleId IdType="pmc">PMC8050350</ArticleId><ArticleId IdType="pubmed">33868292</ArticleId></ArticleIdList></Reference><Reference><Citation>Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduction Targeted Ther (2021) 6(1):291. doi: 10.1038/s41392-021-00687-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-021-00687-0</ArticleId><ArticleId IdType="pmc">PMC8333067</ArticleId><ArticleId IdType="pubmed">34344870</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel M, et al. . Cutting edge: Role of toll-like receptor 9 in CpG DNA-induced activation of human Cells1. J Immunol (2001) 167(7):3555&#x2013;8. doi: 10.4049/jimmunol.167.7.3555</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.167.7.3555</ArticleId><ArticleId IdType="pubmed">11564765</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, et al. . Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature (2010) 464(7285):104&#x2013;7. doi: 10.1038/nature08780</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08780</ArticleId><ArticleId IdType="pmc">PMC2843437</ArticleId><ArticleId IdType="pubmed">20203610</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, Itagaki K, Hauser CJ. Mitochondrial DNA is released by shock and activates neutrophils via p38 map kinase. Shock (2010) 34(1):55&#x2013;9. doi: 10.1097/SHK.0b013e3181cd8c08</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/SHK.0b013e3181cd8c08</ArticleId><ArticleId IdType="pubmed">19997055</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie M, Yang L, Bi X, Wang Y, Sun P, Yang H, et al. . Neutrophil extracellular traps induced by IL8 promote diffuse Large b-cell lymphoma progression via the TLR9 SignalingNETs promote DLBCL progression. Clin Cancer Res (2019) 25(6):1867&#x2013;79. doi: 10.1158/1078-0432.CCR-18-1226</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/1078-0432.CCR-18-1226</ArticleId><ArticleId IdType="pubmed">30446590</ArticleId></ArticleIdList></Reference><Reference><Citation>Miura K, Kodama Y, Inokuchi S, Schnabl B, Aoyama T, Ohnishi H, et al. . Toll-like receptor 9 promotes steatohepatitis by induction of interleukin-1&#x3b2; in mice. Gastroenterology (2010) 139(1):323&#x2013;34.e7. doi: 10.1053/j.gastro.2010.03.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2010.03.052</ArticleId><ArticleId IdType="pmc">PMC4631262</ArticleId><ArticleId IdType="pubmed">20347818</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Martinez I, Santoro N, Chen Y, Hoque R, Ouyang X, Caprio S, et al. . Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9. J Clin Invest (2016) 126(3):859&#x2013;64. doi: 10.1172/JCI83885</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI83885</ArticleId><ArticleId IdType="pmc">PMC4767345</ArticleId><ArticleId IdType="pubmed">26808498</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y, Shen J, Ran Z. Emerging views of mitophagy in immunity and autoimmune diseases. Autophagy (2020) 16(1):3&#x2013;17. doi: 10.1080/15548627.2019.1603547</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2019.1603547</ArticleId><ArticleId IdType="pmc">PMC6984455</ArticleId><ArticleId IdType="pubmed">30951392</ArticleId></ArticleIdList></Reference><Reference><Citation>Caielli S, Athale S, Domic B, Murat E, Chandra M, Banchereau R, et al. . Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J Exp Med (2016) 213(5):697&#x2013;713. doi: 10.1084/jem.20151876</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20151876</ArticleId><ArticleId IdType="pmc">PMC4854735</ArticleId><ArticleId IdType="pubmed">27091841</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber&#xe1; A, Lorenzo N, Garrido G, Mazola Y, Falc&#xf3;n V, Torres AM, et al. . APL-1, an altered peptide ligand derived from human heat-shock protein 60, selectively induces apoptosis in activated CD4+ CD25+ T cells from peripheral blood of rheumatoid arthritis patients. Int Immunopharmacol (2013) 17(4):1075&#x2013;83. doi: 10.1016/j.intimp.2013.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2013.10.010</ArticleId><ArticleId IdType="pubmed">24177275</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Wu J, Du F, Xu H, Sun L, Chen Z, et al. . The cytosolic DNA sensor cGAS forms an oligomeric complex with DNA and undergoes switch-like conformational changes in the activation loop. Cell Rep (2014) 6(3):421&#x2013;30. doi: 10.1016/j.celrep.2014.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.01.003</ArticleId><ArticleId IdType="pmc">PMC3969844</ArticleId><ArticleId IdType="pubmed">24462292</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C, Shang G, Gui X, Zhang X, Bai X-C, Chen ZJ. Structural basis of STING binding with and phosphorylation by TBK1. Nature (2019) 567(7748):394&#x2013;8. doi: 10.1038/s41586-019-1000-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1000-2</ArticleId><ArticleId IdType="pmc">PMC6862768</ArticleId><ArticleId IdType="pubmed">30842653</ArticleId></ArticleIdList></Reference><Reference><Citation>Saitoh T, Fujita N, Hayashi T, Takahara K, Satoh T, Lee H, et al. . Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response. Proc Natl Acad Sci (2009) 106(49):20842&#x2013;6. doi: 10.1073/pnas.0911267106</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0911267106</ArticleId><ArticleId IdType="pmc">PMC2791563</ArticleId><ArticleId IdType="pubmed">19926846</ArticleId></ArticleIdList></Reference><Reference><Citation>Rongvaux A, Jackson R, Harman Christian CD, Li T, West AP, de Zoete Marcel R, et al. . Apoptotic caspases prevent the induction of type I interferons by mitochondrial DNA. Cell (2014) 159(7):1563&#x2013;77. doi: 10.1016/j.cell.2014.11.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.11.037</ArticleId><ArticleId IdType="pmc">PMC4272443</ArticleId><ArticleId IdType="pubmed">25525875</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis MJ, Barnes MR, Blighe K, Goldmann K, Rana S, Hackney JA, et al. . Molecular portraits of early rheumatoid arthritis identify clinical and treatment response phenotypes. Cell Rep (2019) 28(9):2455&#x2013;70.e5. doi: 10.1016/j.celrep.2019.07.091</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2019.07.091</ArticleId><ArticleId IdType="pmc">PMC6718830</ArticleId><ArticleId IdType="pubmed">31461658</ArticleId></ArticleIdList></Reference><Reference><Citation>Muskardin TW, Vashisht P, Dorschner JM, Jensen MA, Chrabot BS, Kern M, et al. . Increased pretreatment serum IFN-&#x3b2;/&#x3b1; ratio predicts non-response to tumour necrosis factor &#x3b1; inhibition in rheumatoid arthritis. Ann Rheum Dis (2016) 75(10):1757&#x2013;62. doi: 10.1136/annrheumdis-2015-208001</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2015-208001</ArticleId><ArticleId IdType="pmc">PMC4860184</ArticleId><ArticleId IdType="pubmed">26546586</ArticleId></ArticleIdList></Reference><Reference><Citation>Willemsen J, Neuhoff M-T, Hoyler T, Noir E, Tessier C, Sarret S, et al. . TNF leads to mtDNA release and cGAS/STING-dependent interferon responses that support inflammatory arthritis. Cell Rep (2021) 37(6):109977. doi: 10.1016/j.celrep.2021.109977</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109977</ArticleId><ArticleId IdType="pubmed">34758308</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodero MP, Tesser A, Bartok E, Rice GI, Della Mina E, Depp M, et al. . Type I interferon-mediated autoinflammation due to DNase II deficiency. Nat Commun (2017) 8(1):2176. doi: 10.1038/s41467-017-01932-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01932-3</ArticleId><ArticleId IdType="pmc">PMC5736616</ArticleId><ArticleId IdType="pubmed">29259162</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawane K, Ohtani M, Miwa K, Kizawa T, Kanbara Y, Yoshioka Y, et al. . Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature (2006) 443(7114):998&#x2013;1002. doi: 10.1038/nature05245</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05245</ArticleId><ArticleId IdType="pubmed">17066036</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai H, Zhang Q. Activation of NLRP3 inflammasome and onset of alzheimer&#x2019;s disease. Front Immunol (2021) 12:701282. doi:&#xa0;10.3389/fimmu.2021.701282</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.701282</ArticleId><ArticleId IdType="pmc">PMC8350495</ArticleId><ArticleId IdType="pubmed">34381452</ArticleId></ArticleIdList></Reference><Reference><Citation>He Y, Hara H, N&#xfa;&#xf1;ez G. Mechanism and regulation of NLRP3 inflammasome activation. Trends Biochem Sci (2016) 41(12):1012&#x2013;21. doi: 10.1016/j.tibs.2016.09.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tibs.2016.09.002</ArticleId><ArticleId IdType="pmc">PMC5123939</ArticleId><ArticleId IdType="pubmed">27669650</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroder K, Tschopp J. The inflammasomes. cell (2010) 140(6):821&#x2013;32. doi: 10.1016/j.cell.2010.01.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.01.040</ArticleId><ArticleId IdType="pubmed">20303873</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z, Liang S, Sanchez-Lopez E, He F, Shalapour S, X-j L, et al. . New mitochondrial DNA synthesis enables NLRP3 inflammasome activation. Nature (2018) 560(7717):198&#x2013;203. doi: 10.1038/s41586-018-0372-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-018-0372-z</ArticleId><ArticleId IdType="pmc">PMC6329306</ArticleId><ArticleId IdType="pubmed">30046112</ArticleId></ArticleIdList></Reference><Reference><Citation>Riley JS, Tait SW. Mitochondrial DNA in inflammation and immunity. EMBO Rep (2020) 21(4):e49799. doi: 10.15252/embr.201949799</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201949799</ArticleId><ArticleId IdType="pmc">PMC7132203</ArticleId><ArticleId IdType="pubmed">32202065</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimada K, Crother TR, Karlin J, Dagvadorj J, Chiba N, Chen S, et al. . Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity (2012) 36(3):401&#x2013;14. doi: 10.1016/j.immuni.2012.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2012.01.009</ArticleId><ArticleId IdType="pmc">PMC3312986</ArticleId><ArticleId IdType="pubmed">22342844</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature (2011) 469(7329):221&#x2013;5. doi:&#xa0;10.1038/nature09663</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09663</ArticleId><ArticleId IdType="pubmed">21124315</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuriakose T, Man SM, Subbarao Malireddi R, Karki R, Kesavardhana S, Place DE, et al. . ZBP1/DAI is an innate sensor of influenza virus triggering the NLRP3 inflammasome and programmed cell death pathways. Sci Immunol (2016) 1(2):aag2045&#x2013;aag. doi:&#xa0;10.1126/sciimmunol.aag2045</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aag2045</ArticleId><ArticleId IdType="pmc">PMC5131924</ArticleId><ArticleId IdType="pubmed">27917412</ArticleId></ArticleIdList></Reference><Reference><Citation>Xian H, Watari K, Sanchez-Lopez E, Offenberger J, Onyuru J, Sampath H, et al. . Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling. Immunity (2022) 55(8):1370&#x2013;85.e8. doi:&#xa0;10.1016/j.immuni.2022.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2022.06.007</ArticleId><ArticleId IdType="pmc">PMC9378606</ArticleId><ArticleId IdType="pubmed">35835107</ArticleId></ArticleIdList></Reference><Reference><Citation>West AP, Khoury-Hanold W, Staron M, Tal MC, Pineda CM, Lang SM, et al. . Mitochondrial DNA stress primes the antiviral innate immune response. Nature (2015) 520(7548):553&#x2013;7. doi:&#xa0;10.1038/nature14156</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14156</ArticleId><ArticleId IdType="pmc">PMC4409480</ArticleId><ArticleId IdType="pubmed">25642965</ArticleId></ArticleIdList></Reference><Reference><Citation>Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, et al. . Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature (2012) 485(7397):251&#x2013;5. doi:&#xa0;10.1038/nature10992</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10992</ArticleId><ArticleId IdType="pmc">PMC3378041</ArticleId><ArticleId IdType="pubmed">22535248</ArticleId></ArticleIdList></Reference><Reference><Citation>Okabe Y, Kawane K, Akira S, Taniguchi T, Nagata S. Toll-like receptor&#x2013;independent gene induction program activated by mammalian DNA escaped from apoptotic DNA degradation. J Exp Med (2005) 202(10):1333&#x2013;9. doi: 10.1084/jem.20051654</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20051654</ArticleId><ArticleId IdType="pmc">PMC2212973</ArticleId><ArticleId IdType="pubmed">16301743</ArticleId></ArticleIdList></Reference><Reference><Citation>Novak EA, Mollen KP. Mitochondrial dysfunction in inflammatory bowel disease. Front Cell Dev Biol (2015) 3:62. doi: 10.3389/fcell.2015.00062</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2015.00062</ArticleId><ArticleId IdType="pmc">PMC4589667</ArticleId><ArticleId IdType="pubmed">26484345</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilera M, Darby T, Melgar S. The complex role of inflammasomes in the pathogenesis of inflammatory bowel diseases&#x2013;lessons learned from experimental models. Cytokine Growth Factor Rev (2014) 25(6):715&#x2013;30. doi: 10.1016/j.cytogfr.2014.04.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2014.04.003</ArticleId><ArticleId IdType="pubmed">24803013</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyapati R, Satsangi J, Ho G. Pathogenesis of crohn&#x2019;s disease. F1000Prime Rep (2015) 2(7):44. doi:&#xa0;10.12703/P7-44</Citation><ArticleIdList><ArticleId IdType="doi">10.12703/P7-44</ArticleId><ArticleId IdType="pmc">PMC4447044</ArticleId><ArticleId IdType="pubmed">26097717</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong Z, Sanchez-Lopez E, Karin M. Autophagy, NLRP3 inflammasome and auto-inflammatory/immune diseases. Clin Exp Rheumatol (2016) 34(4 Suppl 98):12&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">27586797</ArticleId></ArticleIdList></Reference><Reference><Citation>Stacey KJ, Sweet MJ, Hume DA. Macrophages ingest and are activated by bacterial DNA. J Immunol (Baltimore Md: 1950). (1996) 157(5):2116&#x2013;22. doi: 10.4049/jimmunol.157.5.2116</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.157.5.2116</ArticleId><ArticleId IdType="pubmed">8757335</ArticleId></ArticleIdList></Reference><Reference><Citation>Oemer G, Lackner K, Muigg K, Krumschnabel G, Watschinger K, Sailer S, et al. . Molecular structural diversity of mitochondrial cardiolipins. Proc Natl Acad Sci (2018) 115(16):4158&#x2013;63. doi: 10.1073/pnas.1719407115</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1719407115</ArticleId><ArticleId IdType="pmc">PMC5910844</ArticleId><ArticleId IdType="pubmed">29618609</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzuto M, Pelegrin P. Cardiolipin in immune signaling and cell death. Trends Cell Biol (2020) 30(11):892&#x2013;903. doi: 10.1016/j.tcb.2020.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcb.2020.09.004</ArticleId><ArticleId IdType="pubmed">33011017</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzuto M, Lonez C, Baroja-Mazo A, Mart&#xed;nez-Banaclocha H, Tourlomousis P, Gangloff M, et al. . Saturation of acyl chains converts cardiolipin from an antagonist to an activator of toll-like receptor-4. Cell Mol Life Sci (2019) 76:3667&#x2013;78. doi: 10.1007/s00018-019-03113-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-019-03113-5</ArticleId><ArticleId IdType="pmc">PMC6697720</ArticleId><ArticleId IdType="pubmed">31062071</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao C, Ghosh S. NF-&#x3ba;B, an evolutionarily conserved mediator of immune and inflammatory responses. Mech Lymphocyte Activation Immune Regul X: Innate Immun (2005) 560:41&#x2013;5. doi: 10.1007/0-387-24180-9_5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/0-387-24180-9_5</ArticleId><ArticleId IdType="pubmed">15932018</ArticleId></ArticleIdList></Reference><Reference><Citation>Muzio M, Polentarutti N, Bosisio D, Kumar PM, Mantovani A. Toll-like receptor family and signalling pathway. Biochem Soc Trans (2000) 28(5):563&#x2013;6. doi: 10.1042/bst0280563</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0280563</ArticleId><ArticleId IdType="pubmed">11044375</ArticleId></ArticleIdList></Reference><Reference><Citation>Carneiro FR, Lepelley A, Seeley JJ, Hayden MS, Ghosh S. An essential role for ECSIT in mitochondrial complex I assembly and mitophagy in macrophages. Cell Rep (2018) 22(10):2654&#x2013;66. doi: 10.1016/j.celrep.2018.02.051</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.02.051</ArticleId><ArticleId IdType="pmc">PMC5909989</ArticleId><ArticleId IdType="pubmed">29514094</ArticleId></ArticleIdList></Reference><Reference><Citation>Suliman HB, Welty-Wolf KE, Carraway MS, Schwartz DA, Hollingsworth JW, Piantadosi CA. Toll-like receptor 4 mediates mitochondrial DNA damage and biogenic responses after heat-inactivated e. coli. FASEB J (2005) 19(11):1531&#x2013;3. doi: 10.1096/fj.04-3500fje</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.04-3500fje</ArticleId><ArticleId IdType="pubmed">15994412</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney TE, Suliman HB, Hollingsworth JW, Piantadosi CA. Differential regulation of the PGC family of genes in a mouse model of staphylococcus aureus sepsis. PloS One (2010) 5(7):e11606. doi: 10.1371/journal.pone.0011606</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0011606</ArticleId><ArticleId IdType="pmc">PMC2905396</ArticleId><ArticleId IdType="pubmed">20657826</ArticleId></ArticleIdList></Reference><Reference><Citation>Elkon KB, Wiedeman A. Type I IFN system in the development and manifestations of SLE. Curr Opin Rheumatol (2012) 24(5):499&#x2013;505. doi: 10.1097/BOR.0b013e3283562c3e</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/BOR.0b013e3283562c3e</ArticleId><ArticleId IdType="pubmed">22832823</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamerman JA, Pottle J, Ni M, He Y, Zhang ZY, Buckner JH. Negative regulation of TLR signaling in myeloid cells&#x2013;implications for autoimmune diseases. Immunol Rev (2016) 269(1):212&#x2013;27. doi: 10.1111/imr.12381</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12381</ArticleId><ArticleId IdType="pmc">PMC4703580</ArticleId><ArticleId IdType="pubmed">26683155</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Bon L, Popa C, Huijbens R, Vonk M, York M, Simms R, et al. . Distinct evolution of TLR-mediated dendritic cell cytokine secretion in patients with limited and diffuse cutaneous systemic sclerosis. Ann Rheum Dis (2010) 69(8):1539&#x2013;47. doi: 10.1136/ard.2009.128207</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2009.128207</ArticleId><ArticleId IdType="pubmed">20498209</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarda G, Zenger M, Yazdi AS, Schroder K, Ferrero I, Menu P, et al. . Differential expression of NLRP3 among hematopoietic cells. J Immunol (2011) 186(4):2529&#x2013;34. doi: 10.4049/jimmunol.1002720</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1002720</ArticleId><ArticleId IdType="pubmed">21257968</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Guo J, Bi L. Role of the NLRP3 inflammasome in autoimmune diseases. Biomed Pharmacotherapy (2020) 130:110542. doi: 10.1016/j.biopha.2020.110542</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2020.110542</ArticleId><ArticleId IdType="pubmed">32738636</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Liu K, Cheng D, Zheng B, Li S, Mo Z. The regulatory role of NLRX1 in innate immunity and human disease. Cytokine (2022) 160:156055. doi: 10.1016/j.cyto.2022.156055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2022.156055</ArticleId><ArticleId IdType="pubmed">36194971</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauernfeind FG, Horvath G, Stutz A, Alnemri ES, MacDonald K, Speert D, et al. . Cutting edge: NF-&#x3ba;B activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression. J Immunol (2009) 183(2):787&#x2013;91. doi: 10.4049/jimmunol.0901363</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.0901363</ArticleId><ArticleId IdType="pmc">PMC2824855</ArticleId><ArticleId IdType="pubmed">19570822</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakahira K, Haspel JA, Rathinam VA, Lee S-J, Dolinay T, Lam HC, et al. . Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nat Immunol (2011) 12(3):222&#x2013;30. doi: 10.1038/ni.1980</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.1980</ArticleId><ArticleId IdType="pmc">PMC3079381</ArticleId><ArticleId IdType="pubmed">21151103</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer SS, He Q, Janczy JR, Elliott EI, Zhong Z, Olivier AK, et al. . Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity (2013) 39(2):311&#x2013;23. doi: 10.1016/j.immuni.2013.08.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2013.08.001</ArticleId><ArticleId IdType="pmc">PMC3779285</ArticleId><ArticleId IdType="pubmed">23954133</ArticleId></ArticleIdList></Reference><Reference><Citation>Pontillo A, Girardelli M, Kamada AJ, Pancotto JA, Donadi EA, Crovella S, et al. . Polimorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity (2012) 45(4):271&#x2013;8. doi: 10.3109/08916934.2011.637532</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/08916934.2011.637532</ArticleId><ArticleId IdType="pubmed">22235789</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, et al. . NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med (2007) 356(12):1216&#x2013;25. doi: 10.1056/NEJMoa061592</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa061592</ArticleId><ArticleId IdType="pubmed">17377159</ArticleId></ArticleIdList></Reference><Reference><Citation>Magitta N, B&#xf8;e Wolff A, Johansson S, Skinningsrud B, Lie B, Myhr K, et al. . A coding polymorphism in NALP1 confers risk for autoimmune addison&#x2019;s disease and type 1 diabetes. Genes Immunity (2009) 10(2):120&#x2013;4. doi: 10.1038/gene.2008.85</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gene.2008.85</ArticleId><ArticleId IdType="pubmed">18946481</ArticleId></ArticleIdList></Reference><Reference><Citation>Brennan K, Bowie AG. Activation of host pattern recognition receptors by viruses. Curr Opin Microbiol (2010) 13(4):503&#x2013;7. doi: 10.1016/j.mib.2010.05.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mib.2010.05.007</ArticleId><ArticleId IdType="pubmed">20538506</ArticleId></ArticleIdList></Reference><Reference><Citation>Seth RB, Sun L, Ea C-K, Chen ZJ. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-&#x3ba;B and IRF3. Cell (2005) 122(5):669&#x2013;82. doi: 10.1016/j.cell.2005.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2005.08.012</ArticleId><ArticleId IdType="pubmed">16125763</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao W-H, Shu DH, Zhen Y, Hilliard B, Priest SO, Cesaroni M, et al. . Prion-like aggregation of mitochondrial antiviral signaling protein in lupus patients is associated with increased levels of type I interferon. Arthritis Rheumatol (2016) 68(11):2697&#x2013;707. doi: 10.1002/art.39733</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.39733</ArticleId><ArticleId IdType="pmc">PMC5079845</ArticleId><ArticleId IdType="pubmed">27110677</ArticleId></ArticleIdList></Reference><Reference><Citation>Pothlichet J, Niewold TB, Vitour D, Solhonne B, Crow MK, Si-Tahar M. A loss-of-function variant of the antiviral molecule MAVS is associated with a subset of systemic lupus patients. EMBO Mol Med (2011) 3(3):142&#x2013;52. doi: 10.1002/emmm.201000120</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.201000120</ArticleId><ArticleId IdType="pmc">PMC3395111</ArticleId><ArticleId IdType="pubmed">21268286</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun W, Wang H, Qi CF, Wu J, Scott B, Bolland S. Antiviral adaptor MAVS promotes murine lupus with a B cell autonomous role. Front Immunol (2019) 10:2452. doi:&#xa0;10.3389/fimmu.2019.02452</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02452</ArticleId><ArticleId IdType="pmc">PMC6805724</ArticleId><ArticleId IdType="pubmed">31681326</ArticleId></ArticleIdList></Reference><Reference><Citation>Munroe ME, Pezant N, Brown MA, Fife DA, Guthridge JM, Kelly JA, et al. . Association of IFIH1 and pro-inflammatory mediators: Potential new clues in SLE-associated pathogenesis. PloS One (2017) 12(2):e0171193. doi: 10.1371/journal.pone.0171193</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0171193</ArticleId><ArticleId IdType="pmc">PMC5325200</ArticleId><ArticleId IdType="pubmed">28234905</ArticleId></ArticleIdList></Reference><Reference><Citation>Blum SI, Tse HM. Innate viral sensor MDA5 and coxsackievirus interplay in type 1 diabetes development. Microorganisms (2020) 8(7):993. doi: 10.3390/microorganisms8070993</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8070993</ArticleId><ArticleId IdType="pmc">PMC7409145</ArticleId><ArticleId IdType="pubmed">32635205</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu W, Guo L, Fu Y, Wang K, Zhang D, Xu W, et al. . Interstitial lung disease in anti-MDA5 positive dermatomyositis. Clin Rev Allergy Immunol (2021) 60:293&#x2013;304. doi: 10.1007/s12016-020-08822-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-020-08822-5</ArticleId><ArticleId IdType="pubmed">33405101</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Zhang H, Su Y, Zhang B. Application and prospect of targeting innate immune sensors in the treatment of autoimmune diseases. Cell Bioscience. (2022) 12(1):68. doi: 10.1186/s13578-022-00810-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13578-022-00810-w</ArticleId><ArticleId IdType="pmc">PMC9134593</ArticleId><ArticleId IdType="pubmed">35619184</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L, Zhang X, Pu W, Zhao J, Wang K, Zhang D, et al. . WDFY4 polymorphisms in Chinese patients with anti-MDA5 dermatomyositis is associated with rapid progressive interstitial lung disease. Rheumatology (2023). doi: 10.1093/rheumatology/kead006</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kead006</ArticleId><ArticleId IdType="pubmed">36637178</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson T, Kariuki SN, Franek BS, Kumabe M, Kumar AA, Badaracco M, et al. . Autoimmune disease risk variant of IFIH1 is associated with increased sensitivity to IFN-&#x3b1; and serologic autoimmunity in lupus patients. J Immunol (2011) 187(3):1298&#x2013;303. doi: 10.4049/jimmunol.1100857</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1100857</ArticleId><ArticleId IdType="pmc">PMC3304466</ArticleId><ArticleId IdType="pubmed">21705624</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, Zimmermann AG, et al. . NLRX1 is a regulator of mitochondrial antiviral immunity. Nature (2008) 451(7178):573&#x2013;7. doi: 10.1038/nature06501</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06501</ArticleId><ArticleId IdType="pubmed">18200010</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber A, Hontecillas R, Zoccoli-Rodriguez V, Ehrich M, Chauhan J, Bassaganya-Riera J. Exploratory studies with NX-13: oral toxicity and pharmacokinetics in rodents of an orally active, gut-restricted first-in-class therapeutic for IBD that targets NLRX1. Drug Chem toxicology. (2022) 45(1):209&#x2013;14. doi: 10.1080/01480545.2019.1679828</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01480545.2019.1679828</ArticleId><ArticleId IdType="pmc">PMC7182494</ArticleId><ArticleId IdType="pubmed">31650868</ArticleId></ArticleIdList></Reference><Reference><Citation>Leber A, Hontecillas R, Zoccoli-Rodriguez V, Bienert C, Chauhan J, Bassaganya-Riera J. Activation of NLRX1 by NX-13 alleviates inflammatory bowel disease through immunometabolic mechanisms in CD4+ T cells. J Immunol (2019) 203(12):3407&#x2013;15. doi: 10.4049/jimmunol.1900364</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900364</ArticleId><ArticleId IdType="pmc">PMC6904519</ArticleId><ArticleId IdType="pubmed">31694910</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanouriakis A, Kostopoulou M, Alunno A, Aringer M, Bajema I, Boletis JN, et al. . Update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheumatic Dis (2019) 78(6):736&#x2013;45. doi: 10.1136/annrheumdis-2019-215089</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/annrheumdis-2019-215089</ArticleId><ArticleId IdType="pubmed">30926722</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Dell JR, Blakely KW, Mallek JA, Eckhoff PJ, Leff RD, Wees SJ, et al. . Treatment of early seropositive rheumatoid arthritis: a two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheumatism (2001) 44(10):2235&#x2013;41. doi: 10.1002/1529-0131(200110)44:10&lt;2235::AID-ART385&gt;3.0.CO;2-A</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/1529-0131(200110)44:10&lt;2235::AID-ART385&gt;3.0.CO;2-A</ArticleId><ArticleId IdType="pubmed">11665963</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J-Q, Szodoray P, Zeher M. Toll-like receptor pathways in autoimmune diseases. Clin Rev Allergy Immunol (2016) 50:1&#x2013;17. doi: 10.1007/s12016-015-8473-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-015-8473-z</ArticleId><ArticleId IdType="pubmed">25687121</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponticelli C, Moroni G. Hydroxychloroquine in systemic lupus erythematosus (SLE). Expert Opin Drug Safety (2017) 16(3):411&#x2013;9. doi: 10.1080/14740338.2017.1269168</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14740338.2017.1269168</ArticleId><ArticleId IdType="pubmed">27927040</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T, Jiao Y, Zhang X. Immunometabolic pathways and its therapeutic implication in autoimmune diseases. Clin Rev Allergy Immunol (2021) 60(1):55&#x2013;67. doi: 10.1007/s12016-020-08821-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-020-08821-6</ArticleId><ArticleId IdType="pubmed">33179144</ArticleId></ArticleIdList></Reference><Reference><Citation>Min B-K, Park S, Kang H-J, Kim DW, Ham HJ, Ha C-M, et al. . Pyruvate dehydrogenase kinase is a metabolic checkpoint for polarization of macrophages to the M1 phenotype. Front Immunol (2019) 10. doi: 10.3389/fimmu.2019.00944</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00944</ArticleId><ArticleId IdType="pmc">PMC6514528</ArticleId><ArticleId IdType="pubmed">31134063</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerriets VA, Kishton RJ, Nichols AG, Macintyre AN, Inoue M, Ilkayeva O, et al. . Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation. J Clin Invest (2015) 125(1):194&#x2013;207. doi: 10.1172/JCI76012</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI76012</ArticleId><ArticleId IdType="pmc">PMC4382238</ArticleId><ArticleId IdType="pubmed">25437876</ArticleId></ArticleIdList></Reference><Reference><Citation>Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G, et al. . Succinate is an inflammatory signal that induces IL-1&#x3b2; through HIF-1&#x3b1;. Nature (2013) 496(7444):238&#x2013;42. doi: 10.1038/nature11986</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11986</ArticleId><ArticleId IdType="pmc">PMC4031686</ArticleId><ArticleId IdType="pubmed">23535595</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill LAJ, Pearce EJ. Immunometabolism governs dendritic cell and macrophage function. J Exp Med (2015) 213(1):15&#x2013;23. doi:&#xa0;10.1084/jem.20151570</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20151570</ArticleId><ArticleId IdType="pmc">PMC4710204</ArticleId><ArticleId IdType="pubmed">26694970</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenzie ED, Selak MA, Tennant DA, Payne LJ, Crosby S, Frederiksen CM, et al. . Cell-permeating &#x3b1;-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells. Mol Cell Biol (2007) 27(9):3282&#x2013;9. doi: 10.1128/MCB.01927-06</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MCB.01927-06</ArticleId><ArticleId IdType="pmc">PMC1899954</ArticleId><ArticleId IdType="pubmed">17325041</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmieri EM, Gonzalez-Cotto M, Baseler WA, Davies LC, Ghesqui&#xe8;re B, Maio N, et al. . Nitric oxide orchestrates metabolic rewiring in M1 macrophages by targeting aconitase 2 and pyruvate dehydrogenase. Nat Commun (2020) 11(1):698. doi: 10.1038/s41467-020-14433-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-14433-7</ArticleId><ArticleId IdType="pmc">PMC7000728</ArticleId><ArticleId IdType="pubmed">32019928</ArticleId></ArticleIdList></Reference><Reference><Citation>MacMicking J, Xie Q-w, Nathan C. Nitric oxide and macrophage function. Annu Rev Immunol (1997) 15(1):323&#x2013;50. doi: 10.1146/annurev.immunol.15.1.323</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.15.1.323</ArticleId><ArticleId IdType="pubmed">9143691</ArticleId></ArticleIdList></Reference><Reference><Citation>Everts B, Amiel E, van der Windt GJW, Freitas TC, Chott R, Yarasheski KE, et al. . Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood (2012) 120(7):1422&#x2013;31. doi: 10.1182/blood-2012-03-419747</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2012-03-419747</ArticleId><ArticleId IdType="pmc">PMC3423780</ArticleId><ArticleId IdType="pubmed">22786879</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghareghani M, Scavo L, Jand Y, Farhadi N, Sadeghi H, Ghanbari A, et al. . Melatonin therapy modulates cerebral metabolism and enhances remyelination by increasing PDK4 in a mouse model of multiple sclerosis. Front Pharmacol (2019) 10:147. doi: 10.3389/fphar.2019.00147</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2019.00147</ArticleId><ArticleId IdType="pmc">PMC6403148</ArticleId><ArticleId IdType="pubmed">30873027</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng M, Yin N, Chhangawala S, Xu K, Leslie CS, Li MO. Aerobic glycolysis promotes T helper 1 cell differentiation through an epigenetic mechanism. Science (2016) 354(6311):481&#x2013;4. doi: 10.1126/science.aaf6284</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6284</ArticleId><ArticleId IdType="pmc">PMC5539971</ArticleId><ArticleId IdType="pubmed">27708054</ArticleId></ArticleIdList></Reference><Reference><Citation>Wellen KE, Hatzivassiliou G, Sachdeva UM, Bui TV, Cross JR, Thompson CB. ATP-citrate lyase links cellular metabolism to histone acetylation. Science (2009) 324(5930):1076&#x2013;80. doi: 10.1126/science.1164097</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1164097</ArticleId><ArticleId IdType="pmc">PMC2746744</ArticleId><ArticleId IdType="pubmed">19461003</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill LAJ, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol (2016) 16(9):553&#x2013;65. doi: 10.1038/nri.2016.70</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.70</ArticleId><ArticleId IdType="pmc">PMC5001910</ArticleId><ArticleId IdType="pubmed">27396447</ArticleId></ArticleIdList></Reference><Reference><Citation>Everts B, Amiel E, Huang SC-C, Smith AM, Chang C-H, Lam WY, et al. . TLR-driven early glycolytic reprogramming via the kinases TBK1-IKK&#x3b5; supports the anabolic demands of dendritic cell activation. Nat Immunol (2014) 15(4):323&#x2013;32. doi: 10.1038/ni.2833</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2833</ArticleId><ArticleId IdType="pmc">PMC4358322</ArticleId><ArticleId IdType="pubmed">24562310</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen K, Pati R, Jha A, Mishra GP, Prusty S, Chaudhary S, et al. . NCoR1 controls immune tolerance in conventional dendritic cells by fine-tuning glycolysis and fatty acid oxidation. Redox Biol (2023) 59:102575. doi: 10.1016/j.redox.2022.102575</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2022.102575</ArticleId><ArticleId IdType="pmc">PMC9804250</ArticleId><ArticleId IdType="pubmed">36565644</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SC-C, Everts B, Ivanova Y, O&#x2019;Sullivan D, Nascimento M, Smith AM, et al. . Cell-intrinsic lysosomal lipolysis is essential for alternative activation of macrophages. Nat Immunol (2014) 15(9):846&#x2013;55. doi: 10.1038/ni.2956</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2956</ArticleId><ArticleId IdType="pmc">PMC4139419</ArticleId><ArticleId IdType="pubmed">25086775</ArticleId></ArticleIdList></Reference><Reference><Citation>Vats D, Mukundan L, Odegaard JI, Zhang L, Smith KL, Morel CR, et al. . Oxidative metabolism and PGC-1&#x3b2; attenuate macrophage-mediated inflammation. Cell Metab (2006) 4(1):13&#x2013;24. doi: 10.1016/j.cmet.2006.05.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2006.05.011</ArticleId><ArticleId IdType="pmc">PMC1904486</ArticleId><ArticleId IdType="pubmed">16814729</ArticleId></ArticleIdList></Reference><Reference><Citation>Freigang S, Ampenberger F, Weiss A, Kanneganti T-D, Iwakura Y, Hersberger M, et al. . Fatty acid&#x2013;induced mitochondrial uncoupling elicits inflammasome-independent IL-1&#x3b1; and sterile vascular inflammation in atherosclerosis. Nat Immunol (2013) 14(10):1045&#x2013;53. doi: 10.1038/ni.2704</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2704</ArticleId><ArticleId IdType="pubmed">23995233</ArticleId></ArticleIdList></Reference><Reference><Citation>Batista-Gonzalez A, Vidal R, Criollo A, Carre&#xf1;o LJ. New insights on the role of lipid metabolism in the metabolic reprogramming of macrophages. Front Immunol (2020) 10. doi: 10.3389/fimmu.2019.02993</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.02993</ArticleId><ArticleId IdType="pmc">PMC6966486</ArticleId><ArticleId IdType="pubmed">31998297</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv Q, Xing Y, Liu Y, Chen Q, Xu J, Hu L, et al. . Didymin switches M1-like toward M2-like macrophage to ameliorate ulcerative colitis via fatty acid oxidation. Pharmacol Res (2021) 169:105613. doi: 10.1016/j.phrs.2021.105613</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105613</ArticleId><ArticleId IdType="pubmed">33915297</ArticleId></ArticleIdList></Reference><Reference><Citation>Malandrino MI, Fucho R, Weber M, Calderon-Dominguez M, Mir JF, Valcarcel L, et al. . Enhanced fatty acid oxidation in adipocytes and macrophages reduces lipid-induced triglyceride accumulation and inflammation. Am J Physiology-Endocrinology Metab (2015) 308(9):E756&#x2013;E69. doi: 10.1152/ajpendo.00362.2014</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpendo.00362.2014</ArticleId><ArticleId IdType="pubmed">25714670</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Liu Y, Li D, Song J, Xia M. PGC-1&#x3b2; suppresses saturated fatty acid-induced macrophage inflammation by inhibiting TAK1 activation. IUBMB Life (2016) 68(2):145&#x2013;55. doi: 10.1002/iub.1470</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/iub.1470</ArticleId><ArticleId IdType="pubmed">26748475</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg SE, Sena LA, Chandel NS. Mitochondria in the regulation of innate and adaptive immunity. Immunity (2015) 42(3):406&#x2013;17. doi: 10.1016/j.immuni.2015.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.02.002</ArticleId><ArticleId IdType="pmc">PMC4365295</ArticleId><ArticleId IdType="pubmed">25786173</ArticleId></ArticleIdList></Reference><Reference><Citation>Yin X, Zeng W, Wu B, Wang L, Wang Z, Tian H, et al. . PPAR&#x3b1; inhibition overcomes tumor-derived exosomal lipid-induced dendritic cell dysfunction. Cell Rep (2020) 33(3):108278. doi:&#xa0;10.1016/j.celrep.2020.108278</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2020.108278</ArticleId><ArticleId IdType="pmc">PMC7771208</ArticleId><ArticleId IdType="pubmed">33086073</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu X, Jia X, Xu C, Wei Y, Wang Z, Liu G, et al. . Downregulation of NK cell activities in apolipoprotein c-III-induced hyperlipidemia resulting from lipid-induced metabolic reprogramming and crosstalk with lipid-laden dendritic cells. Metabolism (2021) 120:154800. doi: 10.1016/j.metabol.2021.154800</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2021.154800</ArticleId><ArticleId IdType="pubmed">34051224</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Neill LA. A broken krebs cycle in macrophages. Immunity (2015) 42(3):393&#x2013;4. doi: 10.1016/j.immuni.2015.02.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.02.017</ArticleId><ArticleId IdType="pubmed">25786167</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Tong Z, Ding C, Luo F, Wu S, Wu C, et al. . Transcription factor c-maf is a checkpoint that programs macrophages in lung cancer. J Clin Invest (2020) 130(4):2081&#x2013;96. doi: 10.1172/JCI131335</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI131335</ArticleId><ArticleId IdType="pmc">PMC7108920</ArticleId><ArticleId IdType="pubmed">31945018</ArticleId></ArticleIdList></Reference><Reference><Citation>Rath M, M&#xfc;ller I, Kropf P, Closs EI, Munder M. Metabolism via arginase or nitric oxide synthase: Two competing arginine pathways in macrophages. Front Immunol (2014) 5. doi: 10.3389/fimmu.2014.00532</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00532</ArticleId><ArticleId IdType="pmc">PMC4209874</ArticleId><ArticleId IdType="pubmed">25386178</ArticleId></ArticleIdList></Reference><Reference><Citation>Strelko CL, Lu W, Dufort FJ, Seyfried TN, Chiles TC, Rabinowitz JD, et al. . Itaconic acid is a mammalian metabolite induced during macrophage activation. J Am Chem Society (2011) 133(41):16386&#x2013;9. doi: 10.1021/ja2070889</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja2070889</ArticleId><ArticleId IdType="pmc">PMC3216473</ArticleId><ArticleId IdType="pubmed">21919507</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampropoulou V, Sergushichev A, Bambouskova M, Nair S, Vincent EE, Loginicheva E, et al. . Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab (2016) 24(1):158&#x2013;66. doi: 10.1016/j.cmet.2016.06.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2016.06.004</ArticleId><ArticleId IdType="pmc">PMC5108454</ArticleId><ArticleId IdType="pubmed">27374498</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordes T, Wallace M, Michelucci A, Divakaruni AS, Sapcariu SC, Sousa C, et al. . Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J Biol Chem (2016) 291(27):14274&#x2013;84. doi: 10.1074/jbc.M115.685792</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.685792</ArticleId><ArticleId IdType="pmc">PMC4933182</ArticleId><ArticleId IdType="pubmed">27189937</ArticleId></ArticleIdList></Reference><Reference><Citation>Meiser J, Kr&#xe4;mer L, Sapcariu SC, Battello N, Ghelfi J, D&#x2019;Herouel AF, et al. . Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J Biol Chem (2016) 291(8):3932&#x2013;46. doi: 10.1074/jbc.M115.676817</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M115.676817</ArticleId><ArticleId IdType="pmc">PMC4759172</ArticleId><ArticleId IdType="pubmed">26679997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ardawi MSM, Newsholme EA. Glutamine metabolism in lymphocytes of the rat. Biochem J (1983) 212(3):835&#x2013;42. doi: 10.1042/bj2120835</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bj2120835</ArticleId><ArticleId IdType="pmc">PMC1153161</ArticleId><ArticleId IdType="pubmed">6882397</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S, Yang J, Wu Z. The regulatory role of &#x3b1;-ketoglutarate metabolism in macrophages. Mediators Inflammation. (2021) 2021:1&#x2013;7. doi:&#xa0;10.1155/2021/5577577</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/5577577</ArticleId><ArticleId IdType="pmc">PMC8024083</ArticleId><ArticleId IdType="pubmed">33859536</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng M-X, Cao D, Chen Y, Li J-Z, Tu B, Gong J-P. &#x3b1;-ketoglutarate attenuates ischemia-reperfusion injury of liver graft in rats. Biomed Pharmacotherapy (2019) 111:1141&#x2013;6. doi: 10.1016/j.biopha.2018.12.149</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2018.12.149</ArticleId><ArticleId IdType="pubmed">30841427</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Ding L, Liang D, Luo L. Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing &#x3b1;-ketoglutarate production in mice. Mol Oral Microbiol (2018) 33(5):388&#x2013;95. doi: 10.1111/omi.12241</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/omi.12241</ArticleId><ArticleId IdType="pubmed">30007055</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu P-S, Wang H, Li X, Chao T, Teav T, Christen S, et al. . &#x3b1;-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming. Nat Immunol (2017) 18(9):985&#x2013;94. doi: 10.1038/ni.3796</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3796</ArticleId><ArticleId IdType="pubmed">28714978</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>